Apellis Pharmaceuticals to Host Conference Call on November 8, 2021 to Discuss Third Quarter 2021 Financial Results

NEXT STORY
Cabaletta Bio Reports Third Quarter 2021 Financial Results and Provides Business Update
PREV STORY
Medical Devices Market to Hit USD 657.98 Billion by 2028 | Market Size, Share, Trends, Revenue, Competitive Landscape , Forecast, & Trends Analysis Report with COVID-19 Impact by Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

COPENHAGEN, Denmark, November 13, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces ...

author_avatar
NASDAQ Market News

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

Updated label may allow for increased dosing flexibility for patients with hyperkalemia (elevated blood ...

author_avatar
NASDAQ Market News

Radius Health to Present First Health Economics Data on TYMLOS™ (abaloparatide) Injection at the Academy of Managed Care Pharmacy Nexus 2017

Five posters will cover new data on the need for osteoporosis awareness as well ...

author_avatar
NASDAQ Market News